According to the Big Oriental announcement, out of the 8 trading days from November 3 to November 12, 2026, the company's stock rose and stopped for 6 trading days, with a cumulative increase of 81.77% during the period. The Shanghai Composite Index had a cumulative increase of 0.49% during the same period, while the medical services and general retail sectors increased by 2.82% and 4.47% respectively. As of November 11, 2026, the static price-earnings ratio of the company's related industries was about 34.59 to 37.14. The price-earnings ratio for the whole year is expected to be significantly higher than the industry level. The company's revenue for the first three quarters of 2026 was 1,941 million yuan, down 26.61% year on year; net profit to mother was 8.4092 million yuan, down 84.89% year on year, with only slight profit in the first three quarters. There have been no major changes in the company's main business. The current stock price seriously deviates from operating performance and industry conditions. There is a risk of overheating market sentiment, irrational hype, and rapid decline. Investors are kindly requested to make rational decisions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.